Article Information
History
- May 11, 2023.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Young me Yoon1,+,
- Tania E. Velez2,+,
- Vaibhav Upadhyay3,+,
- Sara E. Vazquez4,
- Cathryn T. Lee1,
- Kavitha C. Selvan1,
- Christopher S. Law3,
- Kelly M. Blaine1,
- Maile K. Hollinger1,2,
- Donna C. Decker1,
- Marcus R. Clark1,
- Mary E. Strek1,
- Robert D. Guzy5,
- Ayodeji Adegunsoye1,
- Imre Noth2,
- Paul J. Wolters3,
- Mark Anderson3,
- Joseph L. DeRisi4,
- Anthony K. Shum3,#,* and
- Anne I. Sperling1,2,#,*
- 1University of Chicago, Department of Medicine, Chicago, IL 60637
- 2University of Virginia, Department of Medicine, Charlottesville, VA 22908
- 3University of California San Francisco, Department of Medicine, San Francisco, CA 94143
- 4University of California San Francisco and Chan Zuckerberg Biohub, San Francisco, CA 94158
- 5University of Wisconsin at Madison, Department of Medicine, Madison, WI 53792
- ↵#Corresponding Authors: Anne I. Sperling, PhD
, Professor of Medicine, Division of Pulmonary & Critical Care, Dept of Medicine, Carter Immunology Center, Department of Microbiology, Immunology, and Cancer Biology, University of Virginia, Charlottesville VA 22908, anne.sperling{at}virginia.edu, Anthony Shum, MD
, Professor, Robert L. Kroc Chair in Rheumatic & Connective Tissue Diseases, University of California San Francisco, Division of Pulmonary & Critical Care, 555 Mission Bay Blvd South, San Francisco, CA 94158-3118, Anthony.Shum{at}ucsf.edu
↵* Contributed equally and co-corresponding authors
Posted May 11, 2023.
Antigenic responses are hallmarks of fibrotic interstitial lung diseases independent of underlying etiologies
